{"doi":"10.2147/jpr.s539052","title":"Concurrent Validity of the Operationalization of High-Impact Pain Construct in the Health and Retirement Study","abstract":"Purpose: Chronic pain epidemiology is hindered by inconsistent definitions and methods. The US National Pain Strategy introduced high-impact chronic pain as a pain surveillance standard, defined as chronic pain that interferes with work or life activities. This study aimed to validate the operationalization of high-impact pain in the Health and Retirement Study (HRS), a large, nationally representative cohort of older adults. Patients and Methods: We analyzed data from the 2010 HRS pain module. High-impact pain was operationalized with two questions that have been fielded in the HRS since its inception. Pain intensity and pain-related disability were assessed using numeric rating scales and the Pain Disability Index (PDI). We used Wilcoxon rank-sum tests and logistic regressions to compare high- versus low-impact pain. Pain impact was also assessed at a 2-year follow-up in 2012. Results: Out of 508 participants, 335 (65.9%) reported high-impact pain. Those with high-impact pain had significantly higher pain-related disability (median PDI: 48 [33, 60] vs 19 [8, 36], P<0.0001), average pain intensity (median: 6 [4, 8] vs 5 [3, 6], P<0.0001) and were more likely to report chronic (OR: 1.75 [95% CI: 1.19, 2.58]) and constant (OR: 3.09 [1.93, 4.93]) pain. High-impact pain was associated with a relative risk of 1.80 (1.53, 2.11) for continued high-impact pain at a 2-year follow-up. Conclusion: The HRS operationalization of high-impact pain demonstrates strong concurrent validity with established measures of pain disability, intensity, and impact. The HRS provides a valuable tool for advancing pain research, particularly in aging populations.","journal":"Journal of Pain Research","year":2025,"id":547865,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":1,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.8972,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":378937,"name":"Yenisel Cruz‐Almeida","orcid":"0000-0002-0065-0236","position":1,"is_corresponding":false},{"id":379331,"name":"Javier Tamargo","orcid":"0000-0001-9385-9049","position":0,"is_corresponding":true}],"reference_count":13,"raw_metadata":null,"created_at":"2026-07-19T02:53:53.962932Z","pmid":"41146648","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}